Tag Archives: Loryna

Yasmin, Yaz Blood Clot Risk Updated on Warning Label

April 11, 2012 By: Staff Writers
Beyaz Lawsuit Filed Over Fatal Stroke From New Version of Yaz

March 26, 2012 By: Staff Writers
Women’s Groups Cite Irregularities in FDA Panel Vote Against Yaz Recall

March 19, 2012 By: Staff Writers
Bayer Has Agreed to Settle Yaz Lawsuits Brought by 70 People: Report

March 02, 2012 By: Staff Writers
Lawsuit Over Beyaz Generic Equivalent Filed by Bayer

February 14, 2012 By: Staff Writers
Conflict of Interest Concerns Lead to Calls for New Yaz Safety Meeting

January 17, 2012 By: Staff Writers
Yaz FDA Panelists Served as Consultants, Speakers, Researchers for Bayer

January 12, 2012 By: Staff Writers
Yaz Settlement Negotiations Ordered as First Trial in MDL Delayed

January 03, 2012 By: Staff Writers
Yasmin, Yaz Recall Not Recommended, Stronger Warnings Are: FDA Panel

December 09, 2011 By: Staff Writers
Yasmin, Yaz Warnings Should Be Added: FDA Staff

December 07, 2011 By: Staff Writers

Change Healthcare Data Breach Settlement Talks To Be Explored Early in MDL (Posted 2 days ago)

Court has ordered parties to meet separately with a U.S. Magistrate Judge over the next two months, to discuss the best timing and structure for settlement negotiations to resolve Change Healthcare data breach lawsuits.

Motion Filed To Centralize Depo-Provera Lawsuits in Federal MDL Over Brain Tumor Risks (Posted 3 days ago)

A group of plaintiffs have petitioned the U.S. Judicial Panel on Multidistrict Litigation to consolidate all Depo-Provera lawsuits before one federal judge for coordinated pretrial proceedings.

Tepezza Hearing Damage Emerged After 5 Months of IV Infusions for Thyroid Eye Disease: Lawsuit (Posted 3 days ago)

Lawsuit alleges a man suffered permanent hearing loss after several months of IV infusions of Tepezza, indicating that the drug maker delayed adding warnings to the thyroid eye disease drug label.

Tag Archives: Loryna

Yasmin, Yaz Blood Clot Risk Updated on Warning Label

Beyaz Lawsuit Filed Over Fatal Stroke From New Version of Yaz

Women’s Groups Cite Irregularities in FDA Panel Vote Against Yaz Recall

Bayer Has Agreed to Settle Yaz Lawsuits Brought by 70 People: Report

Lawsuit Over Beyaz Generic Equivalent Filed by Bayer

Conflict of Interest Concerns Lead to Calls for New Yaz Safety Meeting

Yaz FDA Panelists Served as Consultants, Speakers, Researchers for Bayer

Yaz Settlement Negotiations Ordered as First Trial in MDL Delayed

Yasmin, Yaz Recall Not Recommended, Stronger Warnings Are: FDA Panel

Yasmin, Yaz Warnings Should Be Added: FDA Staff

More Top Stories

Review A Case